CVR: 44201666
Previous names: BXT Renal ApS
Vantive ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2023. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named BXT Renal ApS. The management consists of Marianne Schjelderup Brodersen. The company is owned by Vantive Holding B.V.. In 2025, the company reported revenue of DKK 87,089,842 and a net result of DKK 3,905,382 compared with DKK 4,825,752 the year before. Equity amounted to DKK 20,572,247.
Vantive ApS is experiencing a positive financial trajectory, with revenue increasing from 84.4 million DKK in 2024 to 87.1 million DKK in 2025, alongside a profit of 3.9 million DKK. Although the company faced a loss in 2023, it has since improved its equity position to 20.6 million DKK, indicating a recovery and strengthening balance sheet. The profit margin has decreased slightly compared to the previous year, suggesting potential concerns regarding cost management. Overall, Vantive ApS is positioned favorably within the medical supplies wholesale industry, demonstrating growth potential despite past challenges.
AI-generated summary
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er handel med og produktion af medicin og farmaceutiske behandlingsmidler og produkter til brug inden for medicinalindustrien samt anden dermed i forbindelse stående virksomhed.
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 295 companies in Engroshandel med læge- og hospitalsartikler
Comparison is based on industry median values
2 public tenders won
Sources: TED (the EU tender database) and udbud.dk
Screen owners and management against the Danish FSA's official PEP lists
Vantive ApS has published its annual report for 2025. Revenue came to DKK 87,089,842, and the net result was DKK 3,905,382.
As of June 23, 2026, EY Godkendt Revisionspartnerselskab has been appointed auditor of Vantive ApS.
As of June 23, 2026, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Vantive ApS.
Vantive ApS has published its annual report for 2024. Revenue came to DKK 84,356,926, and the net result was DKK 4,825,752.
As of December 18, 2024, Marianne Schjelderup Brodersen is registered as director of Vantive ApS.
As of December 18, 2024, Michal Maciej Smialek has stepped down as director of Vantive ApS.
Vantive ApS has won the tender "Udbudsnummer 1" issued by Amgros I/S worth 333,000,000 DKK.
As of August 28, 2024, Ewa Marianna Gorna-Babiker has joined the board of directors of Vantive ApS.
As of August 28, 2024, Michal Maciej Smialek has left the board of directors of Vantive ApS.
Vantive ApS has published its interim report for the period July 17, 2023 – December 31, 2023.
Vantive ApS has won the tender "Rammeaftale om levering af lægemidler (dialysevæsker), utensilier og natmaskiner til hjemmeperitonealdialyse" issued by Amgros I/S worth 450,000,000 DKK.
As of May 3, 2024, is registered as an owner of Vantive ApS with an ownership share of 100%.
On August 16, 2023, the company changed its name from BXT Renal ApS to Vantive ApS.
As of July 17, 2023, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Vantive ApS.
As of July 17, 2023, Marianne Schjelderup Brodersen has joined the board of directors of Vantive ApS.
As of July 17, 2023, Michal Maciej Smialek has joined the board of directors of Vantive ApS.
As of July 17, 2023, Michal Maciej Smialek is registered as director of Vantive ApS.
Vantive ApS was founded on July 17, 2023.
Companies in the same industry and area
CVR 26400260
CVR 40504044
CVR 37940844
CVR 31412390
CVR 17281402
companydata.dk